Doxorubicin Impairs the Insulin-Like Growth Factor-1 System and Causes Insulin-Like Growth Factor-1 Resistance in Cardiomyocytes

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

New insights into IGF-1 signaling in the heart

(2014) Rodrigo Troncoso et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity

(2013) Marzia Lotrionte et al.   AMERICAN JOURNAL OF CARDIOLOGY

Doxorubicin induces senescence and impairs function of human cardiac progenitor cells

(2013) Elena Piegari et al.   BASIC RESEARCH IN CARDIOLOGY

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

(2012) Yanti Octavia et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Insulin-Like Growth Factor-1 Receptor Identifies a Pool of Human Cardiac Stem Cells With Superior Therapeutic Potential for Myocardial Regeneration

(2011) Domenico D'Amario et al.   CIRCULATION RESEARCH

Wnt Signaling Exerts an Antiproliferative Effect on Adult Cardiac Progenitor Cells Through IGFBP3

(2011) Angelos Oikonomopoulos et al.   CIRCULATION RESEARCH

High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor

(2010) Xi-Yong Yu et al.   EXPERIMENTAL CELL RESEARCH

Androgen Receptor Counteracts Doxorubicin-Induced Cardiotoxicity in Male Mice

(2010) Yasumasa Ikeda et al.   MOLECULAR ENDOCRINOLOGY

Anthracycline Cardiomyopathy Is Mediated by Depletion of the Cardiac Stem Cell Pool and Is Rescued by Restoration of Progenitor Cell Function

(2009) Antonella De Angelis et al.   CIRCULATION

Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease

(2009) Sherryline Jogie-Brahim et al.   ENDOCRINE REVIEWS

Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload

(2009) Norifumi Takeda et al.   JOURNAL OF CLINICAL INVESTIGATION

Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity

(2009) Masashi Yoshida et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Treatment with an adenoviral vector encoding hepatocyte growth factor mitigates established cardiac dysfunction in doxorubicin-induced cardiomyopathy

(2007) Masayasu Esaki et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY